Youths with type 1 diabetes who used an artificial pancreas system had lower incidence of nocturnal hypoglycemia and better control of nocturnal glucose levels than those who used an insulin pump, an Israeli study showed. Researchers found no evidence of severe adverse reactions with the use of the artificial pancreas. The findings appear in the New England Journal of Medicine.

Related Summaries